SPP1 and cancer: These polymorphisms may affect the transcriptional activity of OPN and some of them are thought to be genetic risk factors for disease susceptibility [11–13], of which the rs17524488 (-156 GG/G) polymorphism is most frequently studied, which has been found to associate with several diseases, including hip osteoarthritis [14], cancer [15], and diabetic nephropathy [16].